BRIEF-Naya Biosciences Announces Development Of NY-500
ReutersJan 6, 2025 2:47 PM
Jan 6 (Reuters) - NAYA Biosciences Inc NAYA.O:
NAYA BIOSCIENCES ANNOUNCES DEVELOPMENT OF NY-500, A NOVEL AI-OPTIMIZED PD-1 X VEGF BIFUNCTIONAL ANTIBODY
NAYA BIOSCIENCES INC - TO INITIATE CLINICAL TRIALS IN EARLY 2026
NAYA BIOSCIENCES INC - NY-500 EXPECTED TO ENTER PHASE 1/2A TRIALS IN EARLY 2026
NAYA BIOSCIENCES INC - PHASE 1/2A CLINICAL TRIALS EXPECTED TO START IN 2025
Source text: nGNXbgY01Y
Further company coverage: NAYA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Investing in Industrials Stocks
TradingKey - Industrials are having a remarkable 2025 recovery, quietly but powerfully. No longer a defensively minded, yield-driven sector, they are riding waves of structural change from geopolitics and AI infrastructure to the great global supply chain reshore. While the S&P 500 continues to...TradingKey
8 hours ago
U.S. GDP, PCE, and Fed Rate Decision Commentary: Will U.S. Stocks Continue to Rise?
TradingKey - On 30–31 July 2025, the United States released its latest GDP and PCE data, while the Federal Reserve announced its interest rate decision during the same period.TradingKey
13 hours ago
What Is Binance Coin (BNB), and Can It Really Hit $2,775 by 2028?
BNB is the native token of Binance, the world’s largest crypto exchange. Launched in 2017 via an ICO, BNB started as an ERC-20 token on Ethereum before migrating to BNB Chain, which includes both the Binance Smart Chain (BSC) and Binance Chain.TradingKey
18 hours ago
What to Expect From Meta Q2 Earnings: AI Push, Ad Strength — But Can Profitability Hold?
TradingKey - Meta Platforms (META), the parent company of Facebook, Instagram, and WhatsApp, will release its Q2 2025 earnings after the U.S. market close on Wednesday, July 30. After nine consecutive quarters of beating expectations, analysts expect another strong performance — driven by AI-poweredTradingKey
Tue, Jul 29
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics.TradingKey
Mon, May 26
.jpg)
